Furthermore, PD-1 blockade enriched the population of GPC3-specific CTLs that degranulated against only GPC3-positive liver cancer cell lines (SK-Hep1/vec pulsed with GPC3144–152 peptide, SK-Hep1/GPC3 and HepG2). The gene discussed is GPC3; the disease is liver cancer.